Multifunctional materials for bone cancer treatment

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2713-2725

  Marques, Catarina ^a   Ferreira, José M F ^a   Andronescu, Ecaterina ^b   Ficai, Denisa ^b   Sonmez, Maria ^c   Ficai, Anton ^b  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^c NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR TEXTILES AND LEATHER   (Romania)

Author keywords

Bone graft; Cancer; Collagen; Cytostatics; Magnetite; Silver

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID TETHERED PEP L PEPTIDE CONJUGATED LIPOSOMAL NANOCARRIER; NANOCARRIER; UNCLASSIFIED DRUG;

CANCER CELL LINE; CELL CULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; LIPOSOMAL DELIVERY; PARTICLE SIZE; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; REVIEW; SPECTROPHOTOMETRY; ZETA POTENTIAL;

EID: 84901650259     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s55943     Document Type: Review

References (202)

1. Fratzl P, Weinkamer R. Nature's hierarchical materials. Prog Mater Sci. 2007;52:1263-1334.
2. Silva CC, Thomazini D, Pinheiro AG, et al. Collagen-hydroxyapatite films: piezoelectric properties. Mat Sci Eng B Solid State Mater Adv Technol. 2001;86:210-218.
3. Noris-Suarez K, Lira-Olivares J, Ferreira AM, et al. In Vitro Deposition of Hydroxyapatite on Cortical Bone Collagen Stimulated by Deformation-Induced Piezoelectricity. Biomacromolecules. 2007;8:941-948.
4. von Walterskirchen M. The U.S. Market for Medical Devices-Opportunities and Challenges for Swiss Companies. 2004. Available from: http://www.swissbusinesshub.com/photos/news/SwissMedtech.pdf. Accessed January 7, 2014.
5. Ficai M, Andronescu E, Ficai D, Voicu G, Ficai A. Synthesis and characterization of COLL-PVA/HA hybrid materials with stratified morphology. Colloids Surf B Biointerfaces. 2010;81:614-619.
6. Zhang LH, Tang PF, Zhang W, Xu M, Wang Y. Effect of Chitosan as a Dispersant on Collagen-Hydroxyapatite Composite Matrices. Tissue Eng Part C Methods. 2010;16:71-79.
7. Melville AJ, Rodriguez-Lorenzo LM, Forsythe JS, Gross KA. Drug delivery behaviour of hydroxyapatite and carbonated apatite. Bioceramics. 2004;16:529-532.
8. Kim YH, Song BG, Kim SR, Kim KJ. Drug loaded porous hydroxyapatite and its in vitro release. Bioceramics. 2005;17:423-426.
9. Larena A, Caceres DA, Vicario C, Fuentes A. Release of a chitosan-hydroxyapatite composite loaded with ibuprofen and acetyl-salicylic acid submitted to different sterilization treatments. Appl Surf Sci. 2004;238:518-522.
10. Park J, Lakes RS. Biomaterials: An introduction. New York: Springer; 2007.
11. Derner R, Anderson AC. The bone morphogenic protein. Clin Pediatric Med Surg. 2005;22:607-618.
12. Ficai A, Andronescu E, Voicu G, et al. Self assembled collagen/ hydroxyapatite composite materials. Chem Eng J. 2010;160:794-800.
13. Andronescu E, Voicu G, Ficai M, Mohora IA, Trusca R, Ficai A. Collagen/hydroxyapatite composite materials with desired ceramic properties. J Electr Microscopy (Tokyo). 2011;60:253-259.
14. Ilie A, Andronescu E, Ficai D, et al. New approaches in layer by layer synthesis of collagen/hydroxyapatite composite materials. Cent Eur J Chem. 2011;9:283-289.
15. Vranceanu MD, Saban R, Antoniac I, Albu M, Miculescu F. Development and characterization of novel porous collagen based biocomposite for bone tissue regeneration. UPB Sci Bull, Series B. 2012;74:145-156.
16. Gallie WE, Toronto MB. The histrory of a bone graft. J Bone Joint Surg Am. 1914;s2-12:201-212.
17. Ashby M, Ferreira P, Schodek D, editors. Nanomaterials, Nanotechnologies and Design: An Introduction for Engineers and Architects. Amsterdam. Elsevier; 2009.
18. Chris Arts JJ, Verdonschot N, Schreurs BW, Buma P. The use of a bioresorbable nano-crystalline hydroxyapatite paste in acetabular bone impaction grafting. Biomaterials. 2006;27:1110-1118.
19. Rush SM. Bone graft substitutes: Osteobiologics. Clin Podiatr Med Surg. 2005;22:619-630.
20. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26:5474-5491.
21. Ficai A, Andronescu E, Trandafir V, Ghitulica C, Voicu G. Collagen/hydroxyapatite composite obtained by electric field orientation. Mater Lett. 2010;64:541-544.
22. Ficai A, Andronescu E, Voicu G, Ghitulica C, Ficai D. The influence of collagen support and ionic species on the morphology of collagen/hydroxyapatite composite materials. Mater Charact. 2010;61:402-407.
23. Ficai A, Andronescu E, Voicu G, Manzu D, Ficai M. Layer by layer deposition of hydroxyapatite onto the collagen matrix. Mat Sci Eng C Mater Biol Appl. 2009;29:2217-2220.
24. Wang H, Li Y, Zuo Y, Li J, Ma S, Cheng L. Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering. Biomaterials. 2007;28:3338-3348.
25. Jiang D, Zhang J. Calcium phosphate with well controlled nanostructure for tissue engineering. Curr Appl Phys. 2009;9.
26. Rovira A, Amedee J, Bareille R, Rabaud M. Colonization of a calcium phosphate elastin-solubilized peptide-collagen composite material by human osteoblasts. Biomaterials. 1996;17:1535-1540.
27. Venugopal J, Prabhakaran MP, Zhang YZ, Low S, Choon AT, Ramakrishna S. Biomimetic hydroxyapatite-containing composite nanofibrous substrates for bone tissue engineering. Philos Trans A Math Phys Eng Sci. 2010;368:2065-2081.
28. Fratzl P, Gupta HS, Paschalis EP, Roschger P. Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem. 2004;14:2115-2123.
29. Murugan R, Ramakrishna S. Development of nanocomposites for bone grafting. Compos Sci Technol. 2005;65:2385-2406.
30. Ciobanu CS, Andronescu E, Vasile BS, Trusca R, Predoi D. Preliminary studies on hydroxyapatite doped with europium. UPB Sci Bull, Series B. 2011;73:63-70.
31. Dorozhkin SV. Nanosized and nanocrystalline calcium orthophosphates. Acta Biomater. 2010;6:715-734.
32. Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials. 2010;31:1465-1485.
33. Murugan R, Ramakrishna S. Bioresorbable composite bone paste using polysaccharide based nano hydroxyapatite. Biomaterials. 2004;25:3829-3835.
34. Ficai M, Andronescu E, Ficai A, Voicu G, Vasile BS. Poly Bis-GMA/HA based hybrid composite materials. UPB Sci Bull, Series B. 2011;73:75-84.
35. Gloria A, De Santis R, Ambrosio L. Polymer-based composite scaffolds for tissue engineering. J Appl Biomater Biomech. 2010;8:57-67.
36. Rose FRAJ, Oreffo ROC. Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun. 2002;292:1-7.
37. Scholz MS, Blanchfield JP, Bloom LD, et al. The use of composite materials in modern orthopaedic medicine and prosthetic devices: A review. Compos Sci Technol. 2011;71:1791-1803.
38. Marec-Berard P, Delafosse C, Foussat C. Cancer-related bone pain in children. Arch Pediatrie. 2005;12:191-198.
39. Mantyh P. The science behind metastatic bone pain. Eur J Cancer: Supplements. 2006;4:4-8.
40. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1-18.
41. Cancer Research UK. Cancer worldwide-the global picture. 2008. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/world/the-global-picture. Accessed January 7, 2014.
42. Fotuh MA, Macary S. Factors affecting mechanical water shutoff. J Petrol Technol. 2001;53:58-59.
43. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, editors. Globocan 2008: Cancer Incidence and Mortality Worldwide. Lyon: International Agency for Research on Cancer; 2010.
44. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK, editors. SEER Cancer Statistics Review, 1975-2001, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2001/; 2004.
45. Canadian Cancer Society. Canadian Cancer Statistics 2004. Toronto: National Cancer Institute of Canada; 2004.
46. Fraumeni JF Jr. Stature and malignant tumors of bone in childhood and adolescence. Cancer. 1967;20:967-973.
47. Bleyer A, O'Leary M, Barr R, Ries L, editors. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda (MD): National Cancer Institute; 2006.
48. Orentas R, Hodge JW, B. D. Johnson BD, editors. Cancer Vaccines and Tumor Immunity. Hoboken (NJ): John Wiley and Sons; 2008.
49. Purushotham S, Ramanujan RV. Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomater. 2010;6:502-510.
50. Lubbe AS, Bergemann C, Huhnt W, et al. Preclinical experiences with magnetic drug targeting: Tolerance and efficacy. Cancer Res. 1996;56:4694-701.
51. Gupta R, Bajpai AK. Magnetically Guided Release of Ciprofloxacin from Superparamagnetic Polymer Nanocomposites. J Biomater Sci Polym Ed. 2011;22:893-918.
52. Xu R, Ma J, Sun XC, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res. 2009;19:1031-1034.
53. Gallego Ó, Puntes V. What can nanotechnology do to fight cancer? Breast Cancer Res Treat. 2006;8:788-795.
54. Katti KV, Kannan R, Katti K, et al. Hybrid gold nanoparticles in molecular imaging and radiotherapy. Czechoslovak J Phys. 2006;56:D23-D34.
55. Tanaka T, Decuzzi P, Cristofanilli M, et al. Nanotechnology for breast cancer therapy. Biomed Microdevices. 2008.
56. Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. Polymers for Drug Delivery Systems. Annu Rev Chem Biomol Eng. 2010;1:149-173.
57. Ghosh S, Ghosh S. Recent research and development in synthetic polymer-based drug delivery systems. Journal of Chemical Research. 2004;4:241-246.
58. Apicella A, Cappello B, Delnobile MA, et al. Poly(ethylene oxide)-based delivery systems. Polym Drugs Drug Adm. 1994;545:111-125.
59. Jackson JK, Min W, Cruz TF, et al. A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice. Br J Cancer. 1997;75(7):1014-1020.
60. Suzuki Y, Makino Y. Mucosal drug delivery using cellulose derivatives as a functional polymer. J Control Release. 1999;62(1-2):101-107.
61. Aryal S, Hu CMJ, Zhang L. Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano. 2010;4(1):251-258.
62. Cafaggi S, Russo E, Stefani R, Leardi R, Caviglioli G, Parodi B, et al. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Controll Release. 2007;121:110-123.
63. Han HD, Song CK, Park YS, et al. A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int J Pharm. 2008;350:27-34.
64. Soo PL, Cho J, Grant J, Ho E, Picluette-Miller M, Allen C. Drug release mechanism of paclitaxel from a chitosan-lipid implant system: Effect of swelling, degradation and morphology. Eur J Pharm Biopharm. 2008;69:149-157.
65. Ta HT, Dass CR, Dunstan DE. Injectable chitosan hydrogels for localised cancer therapy. J Controll Release. 2008;126:205-216.
66. Junping W, Takayama K, Nagai T, Maitani Y. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm. 2003;251(1-2):13-21.
67. Kiefer MV, Albert M, McNally, M et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer. 2011;117(7):1498-1505.
68. Armentano I, Dottori M, Fortunati E, Mattioli S, Kenny JM. Biodegradable polymer matrix nanocomposites for tissue engineering: A review. Polym Degrad Stab. 2010;95:2126-2146.
69. Albu MG, Ghica MV, Ficai A, Titorencu I, Popa L. Influence of Freeze-Drying Process on Porosity and Kinetics Release of Collagen-Doxycycline Matrices. Proceedings of the 3rd International Conference on Advanced Materials and Systems. 2010:181-186.
70. Andronescu E, Ficai A, Georgiana M, et al. Collagen-hydroxyapatite/Cisplatin Drug Delivery Systems for Locoregional Treatment of Bone Cancer. Technol Cancer Res Treat. 2013;12:275-284.
71. Titorencu I, Albu MG, Popa L, et al. Collagen-Doxycycline Matrices Used in Tissue Engineering. Farmacia. 2011;59:794-802.
72. Kayal S, Ramanujan RV. Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mat Sci Eng C Mater Biol Appl. 2010;30:484-490.
73. Jadhav KR, Pacharane SS, Koshy PV, Kadam VJ. Smart polymers and their role in drug delivery: A review. Curr Drug Ther. 2010;5:250-261.
74. Medeiros SF, Santos AM, Fessi H, Elaissari A. Stimuli-responsive magnetic particles for biomedical applications. Int J Pharm. 2011;403:139-161.
75. Genin FY, Luo P, Dash AK, inventors. Berkeley Advanced Biomaterials, Inc., assignee. Hydroxyapatite based drug delivery implant for cancer treatment. United States patent US 6767550 B1. July 30, 2004.
76. Schegg B, Hülsmeier AJ, Rutschmann C, Maag C, Hennet T. Core glycosylation of collagen Is initiated by two β(1-O)galactosyltransferases. Mol Cell Biol. 2009;29(4):943-952.
77. Albu MG, Titorencu I, Ghica MV. Collagen gels and matrices for biomedical applications. In: Pignatello R, editor. Biomaterials Applications for Nanomedicine. Rijeka, Croatia: InTech: 2011.
78. Albu MG, Titorencu I, Ghica MV. Collagen-based Drug Delivery Systems for Tissue Engineering. In: Pignatello R, editor. Biomaterials Applications for Nanomedicine. Rijeka, Croatia: InTech; 2011.
79. Nagai T, Suzuki N. Isolation of collagen from fish waste material-skin, bone and fins. Food Chem. 2000;68:277-281.
80. Miller EJ, Martin GR, Piez KA, Powers MJ. Characterization of Chick Bone Collagen and Compositional Changes Associated with Maturation. J Biol Chem. 1967;242:5481-5489.
81. Castro-Cesena AB, Novitskaya EE, Phadke A, Varghese S, McKittrick J. Isolation of Collagen from Cortical Bovine Bone for Preparation of Porous Collagen Sponges. Mechanics of Biological Systems and Materials, Conference Proceedings of the Society for Experimental Mechanics Series. 2013:73-78.
82. Kuboki Y, Shimokawa H, Ono T, Sasaki S. Detection of collagen degradation products in bone. Calcif Tissue Res. 1973;12:303-312.
83. Singh O, Gupta SS, Soni M, Moses S, Shukla S, Mathur RK. Collagen dressing versus conventional dressings in burn and chronic wounds: a retrospective study. J Cutan Aesthet Surg. 2011;4(1):12-16.
84. Klein MB, Engrav LH, Holmes JH, et al. Management of facial burns with a collagen/glycosaminoglycan skin substitute-prospective experience with 12 consecutive patients with large, deep facial burns. Burns. 2005;31(3):257-261.
85. Aust MC, Fernandes D, Kolokythas P, Kaplan HM, Vogt PM. Percutaneous collagen induction therapy: an alternative treatment for scars, wrinkles, and skin laxity. Plast Reconstr Surg. 2008;121(4):1421-1429.
86. Albu MG. Collagen gels and matrices for biomedical applications: Lambert Academic Publishing: Saarbrücken; 2011.
87. Albu MG, Trandafir V, Suflet DM, Chitanu GC, Budrugeac P, Titorencu I. Biocomposites based on collagen and phosphorylated dextran for bone regeneration. J Mater Res. 2012;27:1086-1096.
88. Phienney RB, Schwartz SD, Lee DA, Mondino BJ. Collagen-shields delivery of gentamicin and vancomycin. Arch Ophtalmol. 1988;106 1599-1604.
89. Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev. 2003;55:1679-1698.
90. Bandyopadhyay-Ghosh S. Bone as a Collagen-hydroxyapatite Composite and its Repair. Trends Biomater Artif Organs. 2008;22:112-120.
91. Lickorish D, Ramshaw JAM, Werkmeister JA, Glattauer V, Howlett CR. Collagen-hydroxyapatite composite prepared by biomimetic process. J Biomed Mater Res A. 2004;68A:19-27.
92. Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J. Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials. 2001;22:1705-1711.
93. Cui F-Z, Li Y, Ge J. Self-assembly of mineralized collagen composites. Mater Sci Eng R Rep. 2007;57:1-27.
94. Ficai A, Andronescu E, Ficai D, Sonmez M, Albu MG, Voicu G. Mimicking the morphology of long bone. Cent Eur J Chem. 2012;10:1949-1953.
95. Wahl DA, Czernuszka JT. Collagen-hydroxyapatite composites for hard tissue repair. Eur Cell Mater. 2006;11:43-56.
96. Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59(4-5):234-248.
97. Dorozhkin SV. Amorphous calcium (ortho)phosphates. Acta Biomater. 2010;6:4457-4475.
98. Girones Molera J, Mendez JA, San Roman J. Bioresorbable and nonresorbable polymers for bone tissue engineering. Curr Pharm Des. 2012;18(18):2536-2557.
99. Beachley V, Katsanevakis E, Zhang N, Wen XJ. Highly aligned polymer nanofiber structures: fabrication and applications in tissue engineering. In: Jayakumar R, Nair SV, editors. Biomedical Applications of Polymeric Nanofibers. Vol 246. Heidelberg: Springer; 2012:171-212.
100. Tien WB, Chen MT, Yao PC. Effects of pH and temperature on microstructure and morphology of hydroxyapatite/collagen composites synthesized in vitro. Mater Sci Eng C Mater Biol Appl. 2012;32:2096-2102.
101. Sang L, Huang J, Luo DM, Chen ZH, Li XD. Bone-like nanocomposites based on self-assembled protein-based matrices with Ca2+ capturing capability. J Mater Sci Mater Med. 2010;21:2561-2568.
102. Swetha M, Sahithi K, Moorthi A, Srinivasan N, Ramasamy K, Selvamurugan N. Biocomposites containing natural polymers and hydroxyapatite for bone tissue engineering. Int J Biol Macromol. 2010;47(1):1-4.
103. Szpalski C, Wetterau M, Barr J, Warren SM. Bone tissue engineering: current strategies and techniques-part I: Scaffolds. Tissue Eng Part B Rev. 2012;18(4):246-257.
104. Gardin C, Ferroni L, Favero L et al. Nanostructured biomaterials for tissue engineered bone tissue reconstruction. Int J Mol Sci. 2012;13(1):737-757.
105. Khan F, Dahman Y. A novel approach for the utilization of biocellulose nanofibres in polyurethane nanocomposites for potential applications in bone tissue implants. Des Monomers Polym. 2012;15(1):1-29.
106. Canal C, Ginebra MP. Fibre-reinforced calcium phosphate cements: a review. J Mech Behav Biomed Mater. 2011;4(8):1658-1671.
107. Wagoner Johnson AJ, Herschler BA. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater. 2011;7(1):16-30.
108. Chiara G, Letizia F, Lorenzo F, et al. Nanostructured biomaterials for tissue engineered bone tissue reconstruction. Int J Mol Sci. 2012;13;737-757.
109. Otsuka M, Hirano R. Bone cell activity responsive drug release from biodegradable apatite/collagen nano-composite cements-In vitro dissolution medium responsive vitamin K2 release. Colloids Surface B Biointerfaces. 2011;85:338-342.
110. Wang G, Mostafa NZ, Incani V, Kucharski C, Uludag H. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases. J Biomed Mater Res A. 2012;100(3):684-693.
111. Tsourvakas S. Local antibiotic therapy in the treatment of bone and soft tissue infections. In: Danilla S, editor. Selected topics in plastic reconstructive surgery. Rijeka, Croatia: InTech; 2012:17-44.
112. Martins VC, Goissis G, Ribeiro AC, Marcantônio E Jr, Bet MR. The controlled release of antibiotic by hydroxyapatite: anionic collagen composites. Artif Organs. 1998;22(3):215-221.
113. Amaro Martins VC, Goissis G. Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and orfloxacin/ciprofloxacin. Artif Organs. 2000;24(3):224-230.
114. Golub LM. Special Issue: Clinical Applications of Non-Antbacterial Tetracyclines Introduction. Pharmacol Res. 2011;63:99-101.
115. Ficai A, Andronescu E, Voicu G, Albu MG, Ilie A. Biomimetically synthesis of collagen/hydroxyapatite composite materials. Mat Plast. 2010;47:205-208.
116. Andronescu E, Ficai M, Voicu G, Ficai D, Maganu M, Ficai A. Synthesis and characterization of collagen/hydroxyapatite:magnetite composite material for bone cancer treatment. J Mater Sci-Mater M. 2010;21:2237-2242.
117. Ficai A, Andronescu E, Ghitulica C, et al. Colagen/Hydroxyapatite Interactions in Composite Biomaterials. Mat Plast. 2009;46:11-15.
118. Liu X, Zhao M, Lu J, Ma J, Wei J, Wei S. Cell responses to two kinds of nanohydroxyapatite with different sizes and crystallinities. Int J Nanomed. 2012;7:1239-1250.
119. Galois L, Mainard D. Bone ingrowth into two porous ceramics with different pore sizes: An experimental study. Acta Orthop Belg. 2004;70:598-603.
120. Yunoki S, Ikoma T, Monkawa A, et al. Control of pore structure and mechanical property in hydroxyapatite/collagen composite using unidirectional ice growth. Mater Lett. 2006;60:999-1002.
121. Yunoki S, Ikoma T, Tsuchiya A, et al. Fabrication and mechanical and tissue ingrowth properties of unidirectionally porous hydroxyapatite/collagen composite. J Biomed Mater Res B. 2007;80B:166-173.
122. Soundrapandian C, Sa B, Datta S. Organic-inorganic composites for bone drug delivery. Aaps Pharmscitech. 2009;10:1158-1171.
123. Venugopal J, Prabhakaran MP, Low S, et al. Nanotechnology for nanomedicine and delivery of drugs. Curr Pharm Design. 2008;14:2184-2200.
124. Sanders WE, Sanders CC. Toxicity of Antibacterial Agents: Mechanism of Action on Mammalian Cells. Annu Rev Pharmacol. 1979;19:53-83.
125. Lichter JA, Van Vliet KJ, Rubner MF. Design of antibacterial surfaces and interfaces: Polyelectrolyte multilayers as a multifunctional platform. Macromolecules. 2009;42(22):8573-8586.
126. Schottner G. Hybrid sol-gel-derived polymers: Applications of multifunctional materials. Chem. Mater. 2001;13(10):3422-3435.
127. Kaito T, Myoui A, Saito N et al. Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials. 2005;26(1):73-79.
128. Feng B, Hu DX, Zhang YD. Accelerated Bone Regeneration by Chitosan/Nanometer Hydroxyapatite/Collagen Composite Incorporating BMP-7 Mimetic Peptide. J Hard Tissue Biol. 2012;21:481-487.
129. Li JF, Lin ZY, Zheng QX et al. Repair of rabbit radial bone defects using true bone ceramics combined with BMP-2-related peptide and type I collagen. Mater Sci Eng C Mater Biol Appl. 2010;30(8):1272-1279.
130. Liu LR, Zhang LH, Wang FJ, Zhang QQ. The study of collagen-HA composite with incorporated BMP as bone tissue engineering scaffold. In: Zhang XD, editor. Advanced Biomaterials VI: ASBM6: Proceedings of the 6th Asian Symposium on Biomedical Materials, Emei, Chengdu, China, July 19-22, 2004. Dürnten, Switzerland: Trans Tech; 2005:261-264.
131. Sotome S, Uemura T, Kikuchi M, Chen J, Itoh S, Tanaka J, et al. Synthesis and in vivo evaluation of a novel hydroxyapatite/collagen-alginate as a bone filler and a drug delivery carrier of bone morphogenetic protein. Materials Science & Engineering C-Biomimetic and Supramolecular Systems. 2004;24(3):341-347.
132. Otsuka M, Kuninaga T, Otsuka K, Higuchi WI. Effect of nanostructure on biodegradation behaviors of self-setting apatite/collagen composite cements containing vitamin K2 in rats. J Biomed Mater Res B Appl Biomater. 2006;79(1):176-184.
133. Wang G, Babadagli ME, Uludag H. Bisphosphonate-derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds. Mol Pharm. 2011;8(4):1025-1034.
134. Ficai A, Andronescu E, Ghitulica CD, Ficai D, Voicu G, Albu MG. Process for preparing multifunctional composite materials with possible applicability in the treatment of bone cancer, RO 2010 0001171/20101124.
135. Tu J, Yu M, Lu Y et al. Preparation and antibiotic drug release of mineralized collagen coatings on titanium. J Mater Sci Mater Med. 2012;23(10):2413-2423.
136. Robinson DH, Mauger JW. Drug delivery systems. Am J Hosp Pharm. 1991;48(10):S14-23.
137. Szasz M, Hajdu M, Pesti N et al. In Vitro Efficiency of Vancomycin Containing Experimental Drug Delivery Systems. Acta Microbiol Immunol Hung. 2013;60(4):461-468.
138. Zhang F, Wu J, Kang D, Zhang HB. Development of a complex hydrogel of hyaluronan and PVA embedded with silver nanoparticles and its facile studies on Escherichia coli. J Biomat Sci-Polym E. 2013;24:1410-1425.
139. Wadajkar AS, Bhavsar Z, Ko CY et al. Multifunctional particles for melanoma-targeted drug delivery. Acta Biomater. 2012;8(8):2996-3004.
140. Ruel-Gariepy E, Shive M, Bichara A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm. 2004;57:53-63.
141. Nagarajan S, Reddy BS, Tsibouklis J. In vitro effect on cancer cells: synthesis and preparation of polyurethane membranes for controlled delivery of curcumin. J Biomed Mater Res A. 2011;99:410-417.
142. Kim S, Liu Y, Gaber MW, Bumgardner JD, Haggard WO, Yang Y. Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells. J Biomed Mater Res B Appl Biomater. 2009;90(1):145-155.
143. Dhanikula AB, Panchagnula R. Localized paclitaxel delivery. Int J Pharm. 1999;183:85-100.
144. Fukushima S, Machida M, Akutsu T, et al. Roles of adriamycin and adriamycin dimer in antitumor activity of the polymeric micelle carrier system. Colloid Surfaces B. 1999;16:227-236.
145. Fan HY, Dash AK. Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin un-plants. Int J Pharm. 2001;213:103-116.
146. Iafisco M, Palazzo B, Marchetti M et al. Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals. J Mater Chem. 2009;19:8385-8392.
147. Netz DJA, Sepulveda P, Pandolfelli VC, et al. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm. 2001;213:117-125.
148. Baino F. Biomaterials and implants for orbital floor repair. Acta Biomater. 2011;7:3248-3266.
149. Dorozhkin SV. Calcium Orthophosphate-Based Bioceramics. Materials. 2013;6:3840-3942.
150. Tardei C, Spataru M, Albu FM, Stoleriu S, Ioncea A. Fabrication and Characterization of Porous Tri-Calcium Phosphate Ceramic Microspheres. Rev Rom Mater. 2013;43:41-47. Romanian.
151. Uchida A, Shinto Y, Araki N, Ono K. Slow Release of Anticancer Drugs from Porous Calcium Hydroxyapatite Ceramic. J Orthop Res. 1992;10:440-445.
152. Palazzo B, Iafisco M, Laforgia M, et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater. 2007;17:2180-2188.
153. Barroug A, Glimcher MJ. Hydroxyapatite crystals as a local delivery system for cisplatin: adsorption and release of cisplatin in vitro. J Orthop Res. 2002;20(2):274-280.
154. Iafisco M, Margiotta N. Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum-bisphosphonate complexes in the treatment of bone tumors: A mini-review. J Inorg Biochem. 2012;117:237-247.
155. Niu XF, Feng QL, Wang MB, Guo XD, Zheng QX. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release. 2009;134:111-117.
156. Sotome S, Uemura T, Kikuchi M, et al. Synthesis and in vivo evaluation of a novel hydroxyapatite/collagen-alginate as a bone filler and a drug delivery carrier of bone morphogenetic protein. Mat Sci Eng C-Bio S. 2004;24:341-347.
157. Visser R, Arrabal PM, Becerra J, Rinas U, Cifuentes M. The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. Biomaterials. 2009;30(11):2032-2037.
158. Valimaki VV, Aro HT. Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg. 2006;95:95-102.
159. Papapoulos SE. The role of bisphosphonates in the prevention and treatment of osteoporosis. Am J Med. 1993;95(5A):48S-52S.
160. Titorencu I, Albu MG, Anton F, Georgescu A, Jinga VV. Collagen-dexamethasone and collagen-D3 scaffolds for bone tissue engineering. Mol Cryst Liq Cryst. 2012;555(1):208-217.
161. Zou Q, Li YB, Zhang L, Zuo Y, Li JF, Li JD. Antibiotic delivery system using nano-hydroxyapatite/chitosan bone cement consisting of berberine. J Biomed Mater Res A. 2009;89A:1108-1117.
162. Chen T, Wang R, Xu LQ, Neoh KG, Kang ET. Carboxymethyl chitosan-functionalized magnetic nanoparticles for disruption of biofilms of Staphylococcus aureus and Escherichia coli. Ind Eng Chem Res. 2012;51:13164-172.
163. Tanaka K, Ito A, Kobayashi T, et al. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer. 2005;116:624-633.
164. Di Marco M, Sadun C, Port M, Guilbert I, Couvreur P, Dubernet C. Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomedicine. 2007;2(4):609-622.
165. Mahmoudi M, Simchi A, Imani M, Milani AS, Stroeve P. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. J Phys Chem B. 2008;112(46):14470-14481.
166. Arias JL, Reddy LH, Couvreur P. Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. Langmuir. 2008;24(14):7512-7519.
167. Guo S, Li D, Zhang L, Li J, Wang E. Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery. Biomaterials. 2009;30(10):1881-1889.
168. An J, Yuan XY, Luo QZ, Wang DS. Preparation of chitosan-graft-(methyl methacrylate)/Ag nanocomposite with antimicrobial activity. Polymer International. 2010;59(1):62-70.
169. Sahni G, Gopinath P, Jeevanandam P. A novel thermal decomposition approach to synthesize hydroxyapatite-silver nanocomposites and their antibacterial action against GFP-expressing antibiotic resistant E. coli. Colloids Surf B Biointerfaces. 2013;103:441-447.
170. Samani S, Hossainalipour SM, Tamizifar M, Rezaie HR. In vitro antibacterial evaluation of sol-gel-derived Zn-, Ag-, and (Zn + Ag)-doped hydroxyapatite coatings against methicillin-resistant Staphylococcus aureus. J Biomed Mater Res A. 2013;101(1):222-230.
171. Torres N, Oh S, Appleford M, Dean DD et al. Stability of antibacterial self-assembled monolayers on hydroxyapatite. Acta Biomater. 2010;6(8):3242-3255.
172. Nedelcu I-A, Ficai A, Sonmez M, Ficai D, Oprea O, Andronescu E. Silver based materials for biomedical applications. Curr Org Chem. 2014;18(4):173-182.
173. Bagi CM. Targeting of therapeutic agents to bone to treat metastatic cancer. Adv Drug Deliver Rev. 2005;57:995-1010.
174. Porter JR, Ruckh TT, Popat KC. Bone Tissue Engineering: A Review in Bone Biomimetics and Drug Delivery Strategies. Biotechnol Progr. 2009;25:1539-1560.
175. Dass CR, Ek ETH, Choong PFM. Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing. J Cancer Res Clin Oncol. 2007;133(3):193-198.
176. Chang CH, Kuo TF, Lin CC, et al. Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: A porcine model assessed at 18, 24, and 36 weeks. Biomaterials. 2006;27:1876-1888.
177. Venkatesan J, Pallela R, Bhatnagar I, Kim SK. Chitosan-amylopectin/hydroxyapatite and chitosan-chondroitin sulphate/hydroxyapatite composite scaffolds for bone tissue engineering. Int J Biol Macromol. 2012;51(5):1033-1042.
178. Itokazu M, Esaki M, Yamamoto K, Tanemori T, Kasai T. Local drug delivery system using ceramics: vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block. J Mater Sci-Mater M. 1999;10(4):249-252.
179. Itokazu M, Kumazawa S, Wada E, Wenyi Y. Sustained release of adriamycin from implanted hydroxyapatite blocks for the treatment of experimental osteogenic sarcoma in mice. Cancer Lett. 1996;107(1):11-18.
180. Itokazu M, Sugiyama T, Ohno T, Wada E, Katagiri Y. Development of porous apatite ceramic for local delivery of chemotherapeutic agents. J Biomed Mater Res. 1998;39(4):536-538.
181. Carrle D, Bielack SS. Current strategies of chemotherapy in osteosarcoma. Int Orthop. 2006;30:445-451.
182. Luger N, Mach D, Sevcik M, Mantyh P. Bone cancer pain: from model to mechanism to therapy. J Pain Symptom Manage. 2005;29:S32-46.
183. Foley KM. Advances in Cancer Pain. Arch Neurol. 1999;56:413-417.
184. The Bone and Cancer Foundation. Managing Pain Related to Cancer and Bone. New York: Bone and Cancer Foundation 2011.
185. Bone and Cancer Foundation. Managing Pain Related to Cancer and Bone. New York: Bone and Cancer Foundation; 2011.
186. Pharo GH, Zhou L. Pharmacologic management of cancer pain. J Am Osteopath Assoc. 2005;105:S21-S28.
187. Nersesyan H, Slavin KV. Current approach to cancer pain management: availability and implications of different treatment options. Ther Clin Risk Manag. 2007;3(3):381-400.
188. Grumezescu AM, Andronescu E, Ficai A et al. Synthesis, characterization and biological evaluation of a Fe3O4/C12 core/shell nanosystem. Lett Appl Nanobioscience. 2012;1:31-35.
189. Jadhav SA, Bongiovanni R. Synthesis and organic functionalization approaches for magnetite (Fe3O4) nanoparticles. Adv Mater Lett. 2012;3(5):356-361.
190. Lacroix LM, Carrey J, Respaud M. A frequency-adjustable electromagnet for hyperthermia measurements on magnetic nanoparticles. Rev Sci Instrum. 2008;79(9):093909.
191. Kowal CD, Bertino JR. Possible benefits of hyperthermia to chemotherapy. Cancer Res. 1979;39(6):2285-2289.
192. Campbell JL, Arora J, Cowell SF et al. Quasi-cubic magnetite/silica core-shell nanoparticles as enhanced MRI contrast agents for cancer imaging. PLoS One. 2011;6:e21857.
193. Kawashita M, Kawamura K, Li Z. PMMA-based bone cements containing magnetite particles for the hyperthermia of cancer. Acta Biomater. 2010;6(8):3187-3192.
194. Li Z, Kawamura K, Kawashita M, Kudo TA, Kanetaka H, Hiraoka M. In vitro assessment of poly(methylmethacrylate)-based bone cement containing magnetite nanoparticles for hyperthermia treatment of bone tumor. J Biomed Mater Res A. 2012;100(10):2537-2545.
195. Tampieri A, D'Alessandro T, Sandri M et al. Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite. Acta Biomater. 2012;8(2):843-851.
196. Singh RK, El-Fiqi AM, Patel KD, Kim HW. A novel preparation of magnetic hydroxyapatite nanotubes. Mater Lett. 2012;75:130-133.
197. Gopi D, Ansari MT, Shinyjoy E, Kavitha L. Synthesis and spectroscopic characterization of magnetic hydroxyapatite nanocomposite using ultrasonic irradiation. Spectrochim Acta A Mol Biomol Spectrosc. 2012;87:245-250.
198. Murakami S, Hosono T, Jeyadevan B, Kamitakahara M, Ioku K. Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer. J Ceram Soc Jpn. 2008;116(1357):950-954.
199. Singh RK, Srinivasan A, Kothiyal GP. Evaluation of CaO-SiO2-P2O5-Na2O-Fe2O3 bioglass-ceramics for hyperthermia application. J Mater Sci Mater Med. 2009;20 Suppl 1:S147-S151.
200. O. Bretcanu, E. Verne, Bioactive ferrimagnetic glass-ceramics for magnetic induction hyperthermia. In: NanoScience and Technology Institute, editor. Technical Proceedings of the 2005 NSTI Nanotechnology Conference and Trade Show. Boca Raton (Fl): CRC; 2005:266-269.
201. Beherei HH, Abdel-Aal MS, Shaltout AA, El-Magharby A. Bio-physiochemical characterization of anticancer nano-ceramic polymer scaffold for bone grafting. Pharma Chem. 2012;4(1): 544-551.
202. Kokubo T. Preparation and properties of composite ceramics for biomedical applications. J Jpn Soc Powder Powder Metall. 1990;37: 324-328. Japanese.